For citations:
Nosov A.K., Petrov S.B., Reva S.A., Mamizhev E.M., Novikov R.V., Veliev E.I., Moiseenko V.M. Results of a unicenter randomized study of the safety and efficiency of docetaxel chemotherapy before radical prostatectomy in patients with intermediate- and high-risk prostate cancer: An 11.4-year follow-up. Cancer Urology. 2014;10(4):52-61. (In Russ.) https://doi.org/10.17650/1726-9776-2014-10-4-52-61
Email this article 